IP Library › Assignment 056367/0432

Patent Assignment

Reel/Frame 056367/0432

Change of Name

Recorded: 2021-05-25 Pages: 11

View PDF Order Certified Copy

Assignor

UCB BIOPHARMA SPRL (SOCIETE PRIVEE A RESPONSABILITIE LIMITEE)

Executed: 2019-12-02

Assignee

UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE)

ALLEE DE LA RECHERCHE, 60, BRUSSELS, B-1070, BELGIUM

Covered Property (1)

Crystalline Forms of Seletalisib

Patent: 11,059,820 →

Application: 16/615,992 →

Publication: US 2020/0095246

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.

Corrective Assignment to Correct the Correct Application Number Previously Recorded at Reel: 052065 Frame: 0156. Assignor(S) Hereby Confirms the Assignment. Mar 24, 2020

From: AERTS, LUC LAMBERT JOZEF JAN; ASSAF, GEORGES; CARLY, NICOLAS EDMOND; COOL, VINCENT ADOLPHE CAROL

To: UCB BIOPHARMA SPRL

Reel/Frame 052217/0461 →